人银屑病皮肤和血液中的生物活性脂质介质谱
研究采用靶向和非靶向液相色谱-串联质谱法,定量银屑病患者皮肤和外周血中的生物活性脂质介质,并与健康个体比较。银屑病皮损皮肤富含花生四烯酸代谢物(8-、12-和15-羟基二十碳四烯酸),亚油酸衍生的13-羟基十八碳二烯酸较健康皮肤显著升高(607.9 ng/g vs. 5.4 ng/g,P=0.001)。银屑病皮肤差异伴随血浆抗氧化标志物(包括谷胱甘肽)降低和脂肪分解受损(初级和次级胆汁酸浓度降低)。
要点
- 银屑病皮损皮肤中8-、12-和15-羟基二十碳四烯酸较邻近非皮损皮肤和健康皮肤丰富。
- 13-羟基十八碳二烯酸在银屑病皮损皮肤较健康皮肤显著升高(607.9 ng/g vs. 5.4 ng/g,P=0.001)。
- 银屑病皮肤差异伴随血浆谷胱甘肽等抗氧化标志物降低和初级、次级胆汁酸浓度降低。
核心结论
- 银屑病皮肤和血液具有疾病特异性的生物活性脂质介质表型谱,以omega-6脂肪酸氧化衍生物为代表。
- 这些发现为银屑病病理生理学提供了见解,可能有助于新的生物标志物和治疗。
研究设计与样本
- 研究采用靶向和非靶向液相色谱-串联质谱方法,定量银屑病患者和健康个体皮肤及外周血中的脂质介质。
主要发现
- 银屑病皮损皮肤中8-、12-和15-羟基二十碳四烯酸较邻近非皮损皮肤和健康个体皮肤丰富。
- 亚油酸衍生的13-羟基十八碳二烯酸在银屑病皮损皮肤较健康皮肤显著升高(607.9 ng/g vs. 5.4 ng/g,P=0.001)。
- 银屑病皮肤差异伴随血浆抗氧化标志物(包括谷胱甘肽)降低和脂肪分解受损,表现为初级和次级胆汁酸浓度降低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psoriasis is a chronic immune-mediated disease that represents a unique model for investigating inflammation at local and systemic levels. Bioactive lipid mediators (LMs) are potent compounds reported to play a role in the development and resolution of inflammation. Currently, it is not known to what extent these LMs are involved in psoriasis pathophysiology and related metabolic dysfunction. Here, we use targeted and untargeted liquid chromatography-tandem mass spectrometry approaches to quantify LMs in skin and peripheral blood from psoriasis patients and compared them with those of healthy individuals. Lesional psoriasis skin was abundant in arachidonic acid metabolites, as 8-, 12- and 15-hydroxyeicosatetraenoic acid, compared with adjacent nonlesional and skin from healthy individuals. Additionally, a linoleic acid-derived LM, 13-hydroxyoctadecadienoic acid, was significantly increased compared with healthy skin (607.9 ng/g vs. 5.4 ng/g, P = 0.001). These psoriasis skin differences were accompanied by plasma decreases in antioxidant markers, including glutathione, and impaired lipolysis characterized by lower concentrations of primary and secondary bile acids. In conclusion, our study shows that psoriasis skin and blood have disease-specific phenotype profiles of bioactive LMs represented by omega-6 fatty acid-oxidized derivatives. These findings provide insights into psoriasis pathophysiology that could potentially contribute to new biomarkers and therapeutics.
引用
- Sorokin AV, Domenichiello AF, Dey AK, et al. Bioactive Lipid Mediator Profiles in Human Psoriasis Skin and Blood. J Invest Dermatol. 2018. PMID: 29454560. doi:10.1016/j.jid.2018.02.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。